[ad_1]
(MedPage Today) — Quetiapine (Seroquel) was more clinically effective than lithium as a first-line augmentation option in treatment-resistant depression and likely was more cost-effective, a pragmatic multicenter clinical trial suggested.
Over…
[ad_2]
Source link : https://www.medpagetoday.com/psychiatry/depression/114840
Author :
Publish date : 2025-03-26 19:28:00
Copyright for syndicated content belongs to the linked Source.
Quetiapine May Be Better Option Than Lithium for Treatment-Resistant Depression
Related Posts
